Waters Corporation $WAT Shares Sold by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale cut its holdings in Waters Corporation (NYSE:WAT) by 25.7% during the second quarter, Holdings Channel reports. The institutional investor owned 56,576 shares of the medical instruments supplier’s stock after selling 19,590 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Waters were worth $19,838,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. UMB Bank n.a. raised its stake in Waters by 2.8% in the second quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock valued at $368,000 after buying an additional 29 shares in the last quarter. Integrated Wealth Concepts LLC grew its holdings in shares of Waters by 2.9% during the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the last quarter. FourThought Financial Partners LLC grew its holdings in shares of Waters by 5.1% during the first quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier’s stock worth $243,000 after purchasing an additional 32 shares during the last quarter. Brown Advisory Inc. grew its holdings in shares of Waters by 0.8% during the first quarter. Brown Advisory Inc. now owns 5,498 shares of the medical instruments supplier’s stock worth $2,026,000 after purchasing an additional 42 shares during the last quarter. Finally, Horizon Investments LLC grew its holdings in shares of Waters by 5.2% during the first quarter. Horizon Investments LLC now owns 852 shares of the medical instruments supplier’s stock worth $314,000 after buying an additional 42 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Trading Down 0.1%

Shares of Waters stock opened at $349.04 on Thursday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56. The company has a market capitalization of $20.78 billion, a P/E ratio of 31.47, a P/E/G ratio of 3.24 and a beta of 1.04. The business has a 50 day moving average price of $308.96 and a 200 day moving average price of $323.22.

Waters (NYSE:WAT) last issued its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $608.55 million during the quarter. Sell-side analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. UBS Group reaffirmed a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Wells Fargo & Company lowered their price objective on Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the company a “hold” rating in a report on Tuesday, August 5th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $376.80.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.